Sun Pharmaceutical Industries Ltd.
Snapshot View

1027.65 +19.65 ▲2.0%

03 February 2023, 04:01:00 PM
Volume: 215,954

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.sunpharma.com
Market Cap 246,567.66 Cr.
Enterprise Value(EV) 245,013.49 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 17.55 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 58.54 Trailing Twelve Months Ending 2022-12
Industry PE 32.22 Trailing Twelve Months Ending 2022-12
Book Value / Share 230.51 Trailing Twelve Months Ending 2022-12
Price to Book Value 4.46 Calculated using Price: 1,027.65
Dividend Yield 0.97 Period Ending 2022-03
No. of Shares Subscribed 239.93 Cr. 2,399,334,970 Shares
FaceValue 1
Company Profile
The company is among the largest specialty generic pharmaceutical company and India's top pharmaceutical company. A vertically integrated business and a skilled team enables it to deliver high-quality products, trusted by customers and patients in many countries across the world, at affordable prices.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+1.95%
1 Week
-1.53%
1 Month
+1.83%
3 Month
-1.57%
6 Month
+14.58%
1 Year
+16.33%
2 Year
+63.26%
5 Year
+86.46%
10 Year
+185.54%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 23.15 24.89 19.32 22.51 6.85 8.05 9.66 4.98 7.21
Return on Capital Employed (%) 25.46 25.06 18.64 21.48 8.40 8.68 10.07 5.66 9.25
Return on Assets (%) 16.21 14.60 11.39 14.08 4.24 5.17 6.58 3.54 5.20

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 18,525 25,638 32,982 36,640 38,314 41,409 45,264 46,463 48,011 53,118
Non Curr. Liab. 1,748 2,335 2,170 600 46 77 246 -1,515 -1,364 -2,251
Curr. Liab. 5,990 16,147 13,144 17,887 19,864 17,340 15,706 16,146 17,201 16,701
Minority Int. 1,921 2,851 4,085 3,791 3,884 3,314 3,860 3,017 3,055 3,246
Equity & Liab. 28,184 46,972 52,381 58,917 62,109 62,139 65,077 64,110 66,903 70,814
Non Curr. Assets 9,498 18,056 22,440 25,964 30,473 31,070 33,423 33,668 31,888 31,811
Curr. Assets 18,686 28,916 29,934 32,947 31,636 31,069 31,654 30,442 35,015 39,003
Misc. Exp. not W/O 0
Total Assets 28,184 46,972 52,381 58,917 62,109 62,139 65,077 64,110 66,903 70,814

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 16,080 27,392 28,109 31,308 26,416 29,066 32,838 33,498 38,654 42,402
Other Income 552 566 658 1,030 912 1,059 652 859 1,437 682
Total Income 16,633 27,958 28,767 32,338 27,328 30,125 33,489 34,357 40,092 43,083
Total Expenditure -9,081 -19,543 -19,950 -21,626 -20,881 -22,792 -25,863 -25,030 -28,773 -31,523
PBIDT 7,552 8,414 8,817 10,712 6,447 7,333 7,626 9,327 11,319 11,560
Interest -44 -579 -523 -400 -518 -555 -303 -141 -127 -117
Depreciation -409 -1,195 -1,038 -1,265 -1,500 -1,753 -2,053 -2,080 -2,144 -2,414
Taxation -702 -915 -914 -1,212 -911 -601 -823 -515 -1,076 -771
Exceptional Items -2,517 -238 -685 -951 -1,214 -261 -4,306 -4,567 -3,936
PAT 3,879 5,488 5,657 7,836 2,568 3,209 4,187 2,285 3,406 4,322
Minority Interest -738 -936 -1,113 -882 -447 -542 -407 631 -117 -91
Share Associate -13 1 10 -25 -1 -15 -12 -17 -19
Other Related Items
Consolidated Net Profit 3,141 4,539 4,546 6,964 2,096 2,665 3,765 2,904 3,273 4,212
Adjusted EPS 15 22 19 29 9 11 16 12 14 18

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 3,357 3,959 5,616 6,686 7,082 3,907 2,196 6,555 6,170 8,985
Cash Fr. Inv. -2,635 -2,367 -2,866 -4,372 -4,222 -3,371 -681 -2,589 536 -5,725
Cash Fr. Finan. -665 507 -1,187 -1,889 -2,285 -1,539 -2,731 -5,715 -5,980 -5,193
Net Change 57 2,099 1,563 426 575 -1,003 -1,215 -1,749 726 -1,934
Cash & Cash Eqvt 2,069 4,359 7,286 8,032 8,642 7,906 7,062 5,677 6,273 4,508

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 54.48 54.48 54.48 54.48 54.48 54.48 54.48 54.48 54.48
Public 45.52 45.52 45.52 45.52 45.52 45.52 45.52 45.53 45.52
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 9.01 8.62 6.36 6.52 4.79 5.57 4.04 2.53 1.92

Announcements View Details >>

Fri, 03 Feb 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst/Institutional Investor Meeting
Fri, 03 Feb 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Fri, 03 Feb 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015

Technical Scans View Details >>

Fri, 03 Feb 2023
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Cipla Ltd. 82,812.97 1,026.00 +0.1%
Divi's Laboratories Ltd. 76,573.08 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. 72,577.66 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. 61,039.46 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. 52,289.82 1,545.00 +0.3%
Abbott India Ltd. 44,198.55 20,800.00 +1.5%
Zydus Lifesciences Ltd. 44,030.88 435.00 +0.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Cipla Ltd. Consolidated 2022-12 31.39 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 25.59 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.92 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.70 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.92 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-09 50.12 20,800.00 +1.5%
Zydus Lifesciences Ltd. Consolidated 2022-09 22.71 435.00 +0.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Cipla Ltd. Consolidated 2022-12 3.65 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 6.31 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.30 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.20 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.20 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-09 16.28 20,800.00 +1.5%
Zydus Lifesciences Ltd. Consolidated 2022-09 2.64 435.00 +0.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Cipla Ltd. Consolidated 2022-03 0.04 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 0.00 20,800.00 +1.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 435.00 +0.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Cipla Ltd. Consolidated 2022-03 13.10 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 29.95 20,800.00 +1.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 435.00 +0.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Cipla Ltd. Consolidated 2022-03 13.10 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 29.95 20,800.00 +1.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 435.00 +0.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Cipla Ltd. Consolidated 2022-03 21,763.34 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,800.00 +1.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 435.00 +0.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Cipla Ltd. Consolidated 2022-03 2,559.47 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 798.70 20,800.00 +1.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 435.00 +0.6%

FAQ's On Sun Pharmaceutical Industries Ltd.

What is Sun Pharma Inds. share price?

Can I buy Sun Pharma Inds. shares now?

What is the Dividend Yield of Sun Pharma Inds.?

What is the Market Cap of Sun Pharma Inds.?

What are the key metrics to analyse Sun Pharma Inds.?

What is the 52 Week High and Low of Sun Pharma Inds.?

What is the trend of Sun Pharma Inds. share price?